Sanofi – Aventis Pakistan ltd. sales – net for the period increased by 3.38%, amounting to a total of 9.76 billion Rupees during the nine months ended September, 30th 2017
Company’s Gross Profit for the period increased by 14% 3.6 bilion
Company’s Administrative Expenses and Other operation costs increased by 31.22% and 131.45% respectively
The Profit after tax for the period increased 56.16% reaching 974 million against last year’s nine months profits of Rs. 606 million
The company’s basic earnings per share reached rupees 98.22 against 62.90 rupees in 2016
Comparison of Key Financials
Unconsolidated Profit and Loss Account – For the Nine Months Ended, September 30th 2017
Key Financials
2017
2016
% Change
Amounts in PKR ‘000
Net Sales
9,767,953
9,448,593
3.38%
Cost of Sales
6,123,933
6,256,813
-2.12%
Gross Profit
3,644,020
3,191,780
14.17%
Dist: and Marketing Expenses
1,613,300
1,603,527
0.61%
Administrative Expenses
294,998
224,807
31.22%
Other operating expenses
348,888
150,739
131.45%
Other operating income
35,858
27,331
31.20%
Operating Profit
1,422,692
1,240,038
14.73%
Finance costs
29,405
131,394
-77.62%
Profit before Taxation
1,393,287
1,108,644
25.67%
Taxation
445,987
502,005
-11.16%
Net profit for the period
947,300
606,639
56.16%
Basic and diluted – EPS
98.22
62.90
56.15%
Company release on Earnings Report can be accessed here.
